Spyre Therapeutics Statistics
Total Valuation
SYRE has a market cap or net worth of $1.21 billion. The enterprise value is $873.63 million.
| Market Cap | 1.21B |
| Enterprise Value | 873.63M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SYRE has 36.15 million shares outstanding. The number of shares has increased by 104.59% in one year.
| Shares Outstanding | 36.15M |
| Shares Change (YoY) | +104.59% |
| Shares Change (QoQ) | +60.63% |
| Owned by Insiders (%) | 5.51% |
| Owned by Institutions (%) | 49.50% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,369.33 |
| Forward PS | n/a |
| PB Ratio | 6.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 986.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.68, with zero debt.
| Current Ratio | 10.68 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -160.40% |
| Return on Capital (ROIC) | -131.67% |
| Revenue Per Employee | $29,533 |
| Profits Per Employee | -$11.29M |
| Employee Count | 30 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -26,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +735.87% in the last 52 weeks. The beta is 2.85, so SYRE's price volatility has been higher than the market average.
| Beta (1Y) | 2.85 |
| 52-Week Price Change | +735.87% |
| 50-Day Moving Average | 34.61 |
| 200-Day Moving Average | 20.47 |
| Relative Strength Index (RSI) | 45.03 |
| Average Volume (30 Days) | 499,637 |
Short Selling Information
The latest short interest is 3.56 million, so 9.83% of the outstanding shares have been sold short.
| Short Interest | 3.56M |
| Short Previous Month | 3.01M |
| Short % of Shares Out | 9.83% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, SYRE had revenue of $886,000 and -$338.79 million in losses. Loss per share was -$49.12.
| Revenue | 886,000 |
| Gross Profit | 886,000 |
| Operating Income | -242.30M |
| Pretax Income | -338.82M |
| Net Income | -338.79M |
| EBITDA | -337.85M |
| EBIT | -338.82M |
| Loss Per Share | -$49.12 |
Balance Sheet
The company has $339.60 million in cash and no debt, giving a net cash position of $339.60 million or $9.39 per share.
| Cash & Cash Equivalents | 339.60M |
| Total Debt | n/a |
| Net Cash | 339.60M |
| Net Cash Per Share | $9.39 |
| Equity / Book Value | 184.02M |
| Book Value Per Share | 5.09 |
| Working Capital | 309.55M |
Cash Flow
In the last 12 months, operating cash flow was -$99.91 million and capital expenditures $475,000, giving a free cash flow of -$99.44 million.
| Operating Cash Flow | -99.91M |
| Capital Expenditures | 475,000 |
| Free Cash Flow | -99.44M |
| FCF Per Share | -$14.42 |
Margins
Gross margin is 100.00%, with operating and profit margins of -27,347.97% and -38,238.15%.
| Gross Margin | 100.00% |
| Operating Margin | -27,347.97% |
| Pretax Margin | -38,241.08% |
| Profit Margin | -38,238.15% |
| EBITDA Margin | -38,132.28% |
| EBIT Margin | -38,241.08% |
| FCF Margin | -11,222.91% |
Dividends & Yields
SYRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -104.59% |
| Shareholder Yield | -104.59% |
| Earnings Yield | -27.92% |
| FCF Yield | -8.20% |
Analyst Forecast
The average price target for SYRE is $38.00, which is 13.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 13.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -33.74% |
Stock Splits
The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:25.
| Last Split Date | Sep 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
SYRE has an Altman Z-Score of 4.62 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.62 |
| Piotroski F-Score | 2 |